Evidence map›Paper›PMID 17203245›Full record

ArticleApoptosis : an international journal on programmed cell death2007

Cardiac glycoside induces cell death via FasL by activating calcineurin and NF-AT, but apoptosis initially proceeds through activation of caspases.

Pongali B Raghavendra, Yashin Sreenivasan, Govindarajan T Ramesh, Sunil K Manna

RetractedOpen access · greenAbstract readRetracted Publication
In one paragraph

Article in Apoptosis : an international journal on programmed cell death, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Review
  3. Repurposing of approved cardiovascular drugs.Journal of translational medicine · 2016
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Pongali B RaghavendraLaboratory of Immunology, Centre for DNA Fingerprinting & Diagnostics, Nacharam, Hyderabad, 500076, India.
Yashin Sreenivasan
Govindarajan T Ramesh
Sunil K Manna
Centre for DNA Fingerprinting and Diagnostics · INTexas Southern University · US

Funding

TISSUE CULTURE FACILITY DVMT FOR HYPERTENSION, DIABETES, TOXICOLOGY &AIDS RESG12RR003045 · NCRR · TEXAS SOUTHERN UNIVERSITY · PI SALEH, MAHMOUD A · 1986 to 2011
$13.6M
NCRR NIH HHS G12 RR003045
6 · The paper itself

Abstract

Decrease in caspase activity is a common phenomenon in drug resistance. For effective therapeutic intervention, detection of such agents, which affects other pathway independent of caspases to promote cell death, might be important. Oleandrin, a polyphenolic glycoside induced cell death through activation of caspases in a variety of human tumour cells. In this report we provide evidence that besides caspases activation, oleandrin interacts with plasma membrane, changes fluidity of the membrane, disrupts Na(+)/K(+)-ATPase pump, enhances intracellular free Ca(2+) and thereby activates calcineurin. Calcineurin, in turns, activates nuclear transcription factor NF-AT and its dependent genes such as FasL, which induces cell death as a late response of oleandrin. Cell death at early stages is mediated by caspases where inhibitors partially protected oleandrin-mediated cell death in vector-transfected cells, but almost completely in Bcl-xL-overexpressed cells. Overall, our data suggest that oleandrin might be important therapeutic molecule in case of tumors where cell death pathway occurs due to deregulation of caspase-mediated pathway.

Indexed as

AntibodiesApoptosisbcl-X ProteinCalcineurinCalcineurin InhibitorsCalciumCardenolidesCaspase InhibitorsCaspasesCell Line, TumorCell NucleusCyclosporineDactinomycinDNAEnzyme ActivationEnzyme InhibitorsAntibodiesbcl-X Proteinbenzyloxycarbonyl-valyl-alanyl-aspartic acidCalcineurinCalcineurin InhibitorsCalciumCardenolidesCaspase InhibitorsCaspasesCyclosporineDactinomycinDNAEnzyme InhibitorsFas Ligand ProteinLipidsNFATC Transcription FactorsoleandrinOligopeptidesSodium-Potassium-Exchanging ATPase

Identifiers

PMID17203245
PMCPMC2740376
OpenAlexW1587138655

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.